Notes
immunoglobulin E
References
Park KH, et al. Eperisone-related adverse drug reactions including anaphylaxis: A study on 242 Korean patients. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 572, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Trenque T, et al. Hypocalcemia and denosumab: A comparative study with hypocalcemic drugs 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 575, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Lee C-C, et al. Oral fluoroquinolone and the risk of aortic dissection: A population-based case-crossover study. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 747, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Maumus-Robert S, et al. Fluoroquinolone use and risk of arterial aneurysm or dissection. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 748, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Gouverneur A, et al. A safety signal of venous thromboembolic events with the use of DPP-4 inhibitors: A pharmacovigilance disproportionality analysis. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 75, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Pedersen SA, et al. Hydrochlorothiazide use and risk of merkel cell carcinoma and malignant adnexal skin tumours. 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management : abstr. 850, 22 Aug 2018. Available from: URL: https://www.pharmacoepi.org/meetings/34icpe/
Rights and permissions
About this article
Cite this article
News from 34th ICPE. Reactions Weekly 1721, 10–11 (2018). https://doi.org/10.1007/s40278-018-52047-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52047-2